Literature DB >> 11489924

Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis.

I Vlodavsky1, Y Friedmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11489924      PMCID： PMC209369          DOI： 10.1172/JCI13662

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  34 in total

Review 1.  Functions of cell surface heparan sulfate proteoglycans.

Authors:  M Bernfield; M Götte; P W Park; O Reizes; M L Fitzgerald; J Lincecum; M Zako
Journal:  Annu Rev Biochem       Date:  1999       Impact factor: 23.643

2.  Expression of heparanase in normal, dysplastic, and neoplastic human colonic mucosa and stroma. Evidence for its role in colonic tumorigenesis.

Authors:  Y Friedmann; I Vlodavsky; H Aingorn; A Aviv; T Peretz; I Pecker; O Pappo
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

3.  Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis.

Authors:  G Bergers; R Brekken; G McMahon; T H Vu; T Itoh; K Tamaki; K Tanzawa; P Thorpe; S Itohara; Z Werb; D Hanahan
Journal:  Nat Cell Biol       Date:  2000-10       Impact factor: 28.824

4.  Cloning and expression profiling of Hpa2, a novel mammalian heparanase family member.

Authors:  E McKenzie; K Tyson; A Stamps; P Smith; P Turner; R Barry; M Hircock; S Patel; E Barry; C Stubberfield; J Terrett; M Page
Journal:  Biochem Biophys Res Commun       Date:  2000-10-05       Impact factor: 3.575

5.  Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis.

Authors:  L Borsig; R Wong; J Feramisco; D R Nadeau; N M Varki; A Varki
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

6.  Astrocytes contribute to the brain-metastatic specificity of melanoma cells by producing heparanase.

Authors:  D Marchetti; J Li; R Shen
Journal:  Cancer Res       Date:  2000-09-01       Impact factor: 12.701

7.  Tumor metastasis and the reciprocal regulation of prometastatic and antimetastatic factors by nuclear factor kappaB.

Authors:  V B Andela; E M Schwarz; J E Puzas; R J O'Keefe; R N Rosier
Journal:  Cancer Res       Date:  2000-12-01       Impact factor: 12.701

8.  Genomic organization and chromosome localization of the newly identified human heparanase gene.

Authors:  J Dong; A K Kukula; M Toyoshima; M Nakajima
Journal:  Gene       Date:  2000-08-08       Impact factor: 3.688

9.  Identification of active-site residues of the pro-metastatic endoglycosidase heparanase.

Authors:  M D Hulett; J R Hornby; S J Ohms; J Zuegg; C Freeman; J E Gready; C R Parish
Journal:  Biochemistry       Date:  2000-12-26       Impact factor: 3.162

10.  Processing of the human heparanase precursor and evidence that the active enzyme is a heterodimer.

Authors:  M B Fairbanks; A M Mildner; J W Leone; G S Cavey; W R Mathews; R F Drong; J L Slightom; M J Bienkowski; C W Smith; C A Bannow; R L Heinrikson
Journal:  J Biol Chem       Date:  1999-10-15       Impact factor: 5.157
View more
  180 in total

Review 1.  The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis.

Authors:  C Chang; Z Werb
Journal:  Trends Cell Biol       Date:  2001-11       Impact factor: 20.808

2.  Six blind men and the elephant--the many faces of heparan sulfate.

Authors:  Ajit Varki
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

3.  Expression of heparanase in vascular cells and astrocytes of the mouse brain after focal cerebral ischemia.

Authors:  Jimei Li; Jin-Ping Li; Xiao Zhang; Zhongyang Lu; Shan Ping Yu; Ling Wei
Journal:  Brain Res       Date:  2011-11-19       Impact factor: 3.252

4.  Tricyclic antidepressant amitriptyline activates fibroblast growth factor receptor signaling in glial cells: involvement in glial cell line-derived neurotrophic factor production.

Authors:  Kazue Hisaoka; Mami Tsuchioka; Ryoya Yano; Natsuko Maeda; Naoto Kajitani; Norimitsu Morioka; Yoshihiro Nakata; Minoru Takebayashi
Journal:  J Biol Chem       Date:  2011-04-22       Impact factor: 5.157

5.  Activin A binds to perlecan through its pro-region that has heparin/heparan sulfate binding activity.

Authors:  Shaoliang Li; Chisei Shimono; Naoko Norioka; Itsuko Nakano; Tetsuo Okubo; Yoshiko Yagi; Maria Hayashi; Yuya Sato; Hitomi Fujisaki; Shunji Hattori; Nobuo Sugiura; Koji Kimata; Kiyotoshi Sekiguchi
Journal:  J Biol Chem       Date:  2010-09-15       Impact factor: 5.157

6.  Regenerating matrix-based therapy for chronic wound healing: a prospective within-subject pilot study.

Authors:  Suzanne L Groah; Alexander Libin; Miriam Spungen; Kim-Loan Nguyen; Earthaleen Woods; Marjan Nabili; Jessica Ramella-Roman; Denis Barritault
Journal:  Int Wound J       Date:  2010-11-16       Impact factor: 3.315

7.  The endoglycosidase heparanase enters the nucleus of T lymphocytes and modulates H3 methylation at actively transcribed genes via the interplay with key chromatin modifying enzymes.

Authors:  Yi Qing He; Elissa L Sutcliffe; Karen L Bunting; Jasmine Li; Katharine J Goodall; Ivan K A Poon; Mark D Hulett; Craig Freeman; Anjum Zafar; Russell L McInnes; Toshiki Taya; Christopher R Parish; Sudha Rao
Journal:  Transcription       Date:  2012 May-Jun

8.  The Quantification of Glycosaminoglycans: A Comparison of HPLC, Carbazole, and Alcian Blue Methods.

Authors:  Sarah B Frazier; Kevin A Roodhouse; Dennis E Hourcade; Lijuan Zhang
Journal:  Open Glycosci       Date:  2008-01-01

9.  Heparanase augments epidermal growth factor receptor phosphorylation: correlation with head and neck tumor progression.

Authors:  Victoria Cohen-Kaplan; Ilana Doweck; Inna Naroditsky; Israel Vlodavsky; Neta Ilan
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

10.  A novel human heparanase splice variant, T5, endowed with protumorigenic characteristics.

Authors:  Uri Barash; Victoria Cohen-Kaplan; Gil Arvatz; Svetlana Gingis-Velitski; Flonia Levy-Adam; Ofer Nativ; Ronen Shemesh; Michal Ayalon-Sofer; Neta Ilan; Israel Vlodavsky
Journal:  FASEB J       Date:  2009-12-09       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.